Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
September 27, 2023
The UK is, hopefully, coming out of its nadir in international development. This is marked by planned rises in development spend, an ambitious new international development white paper, a supportive Minister, and a new parliament in 2024. But before considering any proposal, future governments with ...
Blog Post
September 05, 2023
Today the Africa Centers for Disease Control’s (ACDC) Health Economics Programme (HEP) has published a new policy brief on the cost-effectiveness of two COVID-19 oral antivirals (COAVs), a nirmatrelvir/ritonavir combination, developed by Pfizer and sold under the name Paxlovid, and Molnupiravir, dev...
Blog Post
August 22, 2023
A recent, thought-provoking blog by our colleague, Justin Sandefur, titled “How Economists got Africa’s AIDS Epidemic Wrong”, has sparked a debate about the historical role of cost-effectiveness analysis in assessing the investments of the President's Emergency Plan for AIDS Relief (PEPFAR) and, imp...
Blog Post
September 22, 2022
The UK is being asked for £1.8 billion, making this one of the biggest decisions facing James Cleverly, the new Secretary of State, within his first two weeks of the job. We will review what is known about the FCDO’s likely commitment, and recommend four key questions that the new Secretary of State...
Blog Post
April 28, 2022
In the past two years, we have all learned that the end of a COVID-19 wave is the end of a chapter, not the end of the story. Ongoing COVID transmission means the risk of new variants of pandemic potential is ever present and vaccination remains our best defence. The primary near-term challenges for...